The prognostic role of comorbidity in salivary gland carcinoma

Cancer

Volumn 113, Issue 7, 2008, Pages 1572-1579

  Terhaard, Chris H J ^a   Van Der Schroeff, Marc P ^b   Van Schie, Kim ^b   Eerenstein, Simone E J ^c   Lubsen, Herman ^a   Kaanders, Johannes H A M ^d   Smeele, Ludwig E ^e   Burlage, Fred R ^f   Van Den Ende, Piet L ^g   Baatenburg De Jong, Robert J ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^f UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^g MAASTRO CLINIC   (Netherlands)

Author keywords

Comorbidity; Disease free survival; Head and neck cancer; Malignant salivary gland tumors; Multivariate analysis; Overall survival; Prognostic factors

Indexed keywords

ADOLESCENT; ADULT; AGED; ALCOHOLISM; ARTICLE; CHILD; COMORBIDITY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SALIVARY GLAND TUMOR; SMOKING; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALCOHOLISM; CHILD; COMORBIDITY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SALIVARY GLAND NEOPLASMS; SMOKING; SURVIVAL RATE;

EID: 54049090415     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23771     Document Type: Article

References (42)

1. Piccirillo JF. Importance of comorbidity in head and neck cancer. Laryngoscope. 2000;110:593-602. (Pubitemid 30198711)
2. Derks W, de Leeuw JR, Hordijk GJ, et al. Reasons for nonstandard treatment in elderly patients with advanced head and neck cancer. Eur Arch Otorhinolaryngol. 2005;262:21-26. (Pubitemid 40386240)
3. Hall SF, Rochon PA, Streiner DL, et al. Measuring comorbidity in patients with head and neck cancer. Laryngoscope. 2002;112:1988-1996. (Pubitemid 35283461)
4. Sanabria A, Carvalho AL, Vartanian JG, Magrin J, Ikeda MK, Kowalski LP. Comorbidity is a prognostic factor in elderly patients with head and neck cancer. Ann Surg Oncol. 2007;14:1449-1457. (Pubitemid 46536825)
5. Singh B, Bhaya M, Zimbler M, et al. Impact of comorbidity on outcome of young patients with head and neck squamous cell carcinoma. Head Neck. 1998;20:1-7.
6. Kaplan MH, Feinstein AR. The importance of classifying initial comorbidity in evaluating the outcome of diabetes mellitus. J Chronic Dis. 1974;27:387-404.
7. Piccirillo JF, Tierney RM, Costas I, Grove L, Spitznagel EL Jr. Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA. 2004;291:2441-2447. (Pubitemid 38669187)
8. Piccirillo JF, Creech C, Zequeira R, Anderson S, Johnston AS. Inclusion of comorbidity into oncology data registries. J Registry Manage. 1999;26:66-70.
9. Terhaard CH, Lubsen H, Van der Tweel I, et al. Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch Head and Neck Oncology Cooperative Group. Head Neck. 2004;26:681-692; discussion 692-693.
10. Terhaard CH, Lubsen H, Rasch CR, et al. The role of radiotherapy in the treatment of malignant salivary gland tumors. Int J Radiat Oncol Biol Phys. 2005;61:103-111. (Pubitemid 40039111)
11. Terhaard C, Lubsen H, Tan B, et al. Facial nerve function in carcinoma of the parotid gland. Eur J Cancer. 2006;42:2744-2750. (Pubitemid 44584659)
12. American Joint Committee on Cancer. Major salivary glands (parotid, submandibular, and sublingual). In: Greene FL, Page DL, Fleming ID, et al, eds. AJCC Cancer Staging Manual, 6th ed. New York, NY: Springer-Verlag; 2002:53-58.
13. Ferrier MB, Spuesens EB, Le Cessie S, et al. Comorbidity as a major risk factor for mortality and complications in head and neck surgery. Arch Otolaryngol Head Neck Surg. 2005;131:27-32.
14. Borggreven PA, Kuik DJ, Quak JJ, et al. Comorbid condition as a prognostic factor for complications in major surgery of the oral cavity and oropharynx with microvascular soft tissue reconstruction. Head Neck. 2003;25:808-815. (Pubitemid 37139893)
15. Rogers SN, Aziz A, Lowe D, Husband DJ. Feasibility study of the retrospective use of the Adult Comorbidity Evaluation index (ACE-27) in patients with cancer of the head and neck who had radiotherapy. Br J Oral Maxillofac Surg. 2006;44:283-288. (Pubitemid 43923719)
16. Renehan A, Gleave EN, Hancock BD, Smith P, McGurk M. Long-term follow-up of over 1000 patients with salivary gland tumors treated in a single centre. Br J Surg. 1996;83:1750-1754. (Pubitemid 26421878)
17. Therkildsen MH, Christensen M, Andersen LJ, Schiodt T, Hansen HS. Salivary gland carcinomas - prognostic factors. Acta Oncol. 1998;37:701-713. (Pubitemid 29066825)
18. Bell RB, Dierks EJ, Homer L, et al. Management and outcome of patients with malignant salivary gland tumors. J Oral Maxillofac Surg. 2005;63:917-928. (Pubitemid 40897743)
19. Hocwald E, Korkmaz H, Yoo GH, et al. Prognostic factors in major salivary gland cancer. Laryngoscope. 2001;111:1434-1439. (Pubitemid 32730192)
20. North CA, Lee DJ, Piantadosi S, Zahurak M, Johns ME. Carcinoma of the major salivary glands treated by surgery or surgery plus postoperative radiotherapy. Int J Radiat Oncol Biol Phys. 1990;18:1319-1326. (Pubitemid 20234142)
21. Spiro RH, Armstrong J, Harrison L, Geller NL, Lin SY, Strong EW. Carcinoma of major salivary glands. Recent trends. Arch Otolaryngol Head Neck Surg. 1989;115:316-321. (Pubitemid 19083161)
22. Jones AS, Beasley NJ, Houghton DJ, Helliwell TR, Husband DJ. Tumors of the minor salivary glands. Clin Otolaryngol Allied Sci. 1998;23:27-33.
23. Lopes MA, Santos GC, Kowalski LP. Multivariate survival analysis of 128 cases of oral cavity minor salivary gland carcinomas. Head Neck. 1998;20:699-706. (Pubitemid 28462825)
24. Parsons JT, Mendenhall WM, Stringer SP, Cassisi NJ, Million RR. Management of minor salivary gland carcinomas. Int J Radiat Oncol Biol Phys. 1996;35:443-454. (Pubitemid 26242891)
25. Frankenthaler RA, Luna MA, Lee SS, et al. Prognostic variables in parotid gland cancer. Arch Otolaryngol Head Neck Surg. 1991;117:1251-1256.
26. Gallo O, Franchi A, Bottai GV, Fini-Storchi I, Tesi G, Boddi V. Risk factors for distant metastases from carcinoma of the parotid gland. Cancer. 1997;80:844-851. (Pubitemid 27360464)
27. Garden AS, El-Naggar AK, Morrison WH, Callender DL, Ang KK, Peters LJ. Postoperative radiotherapy for malignant tumors of the parotid gland. Int J Radiat Oncol Biol Phys. 1997;37:79-85. (Pubitemid 27090137)
28. Kane WJ, McCaffrey TV, Olsen KD, Lewis JE. Primary parotid malignancies. A clinical and pathologic review. Arch Otolaryngol Head Neck Surg. 1991;117:307-315.
29. Poulsen MG, Pratt GR, Kynaston B, Tripcony LB. Prognostic variables in malignant epithelial tumors of the parotid. Int J Radiat Oncol Biol Phys. 1992;23:327-332.
30. Theriault C, Fitzpatrick PJ. Malignant parotid tumors. Prognostic factors and optimum treatment. Am J Clin Oncol. 1986;9:510-516. (Pubitemid 17205981)
31. Vander Poorten V, Balm AJ, Hilgers FJ, et al. The development of a prognostic score for patients with parotid carcinoma. Cancer. 1999;85:2057-2067. (Pubitemid 29202782)
32. Lima RA, Tavares MR, Dias FL, et al. Clinical prognostic factors in malignant parotid gland tumors. Otolaryngol Head Neck Surg. 2005;133:702-708. (Pubitemid 41586057)
33. Bhattacharyya N, Fried MP. Determinants of survival in parotid gland carcinoma: a population-based study. Am J Otolaryngol Head Neck Med Surg. 2005;26:39-44. (Pubitemid 40038074)
34. Carillo JF, Vazquez R, Ramirez-Ortega MC, et al. Multivariate prediction of the probability of recurrence in patients with carcinoma of the parotid gland. Cancer. 2007;109:2043-2051. (Pubitemid 46744199)
35. Paleri V, Wight RG. Applicability of the Adult Comorbidity Evaluation-27 and the Charlson indexes to assess comorbidity by notes extraction in a cohort of United Kingdom patients with head and neck cancer: a retrospective study. J Laryngol Otol. 2002;116:200-205. (Pubitemid 34214430)
36. Paleri V, Wight RG. A cross-comparison of retrospective notes extraction and combined notes extraction and patient interview in the completion of a comorbidity index (ACE-27) in a cohort of United Kingdom patients with head and neck cancer. J Laryngol Otol. 2002;116:937-941. (Pubitemid 35370446)
37. Rogers LQ, Courneya KS, Malone J, et al. Physical activity and quality of life in head and neck cancer survivors. Support Care Cancer. 2006;14:1012-1019. (Pubitemid 44451306)
38. Sesterhenn AM, Teymoortasch A, Folz BJ, et al. Head and neck cancer in the elderly: a cohort study in 40 patients. Acta Oncol. 2005;44:59-64. (Pubitemid 40249129)
39. Allareddy V, Konety BR. Characteristics of patients and predictors of in-hospital mortality after hospitalization for head and neck cancers. Cancer. 2006;106:2382-2388. (Pubitemid 43787662)
40. Park SM, Lim MK, Shin SA, et al. Impact of prediagnosis smoking, alcohol, obesity, and insulin resistance on survival in male cancer patients: National Health Insurance Corporation Study. J Clin Oncol. 2006;24:5017-5024.
41. Derks W, de Leeuw RJ, Hordijk GJ. Elderly patients with head and neck cancer: the influence of comorbidity on choice of therapy, complication rate, and survival. Curr Opin Otolaryngol Head Neck Surg. 2005;13:92-96. (Pubitemid 40388250)
42. Hollenbeak CS, Stack BC, Daley SM, et al. Using comorbidity indexes to predict costs for head and neck cancer. Arch Otolaryngol Head Neck Surg. 2007;133:124-127.